TRULANCE 3 MG — DIN 02493012
PLECANATIDE : 3 MG · BAUSCH HEALTH, CANADA INC. · TABLET · wholesale supply in Canada
Health Canada status: MARKETED
What is TRULANCE?
TRULANCE 3 MG contains PLECANATIDE : 3 MG. It is listed in the Health Canada Drug Product Database under DIN 02493012, held by BAUSCH HEALTH, CANADA INC., supplied as TABLET for ORAL administration. Health Canada currently lists it as marketed, status dated 12-Jan-2022. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is TRULANCE used for?
Treatment of irritable bowel syndrome with constipation (IBS-C) and chronic idiopathic constipation (CIC) in adults.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
How is it supplied and stored?
Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.
| Strength on the label | 3 MG |
|---|---|
| Dosage form | TABLET |
| Route | ORAL |
| Pack configuration (monograph) | White HDPE bottles of 7-count and 30-count tablets; aluminum foil unit dose blister packs of 7-count and 30-count tablets. |
| Storage | Not explicitly detailed in provided text snippet (refer to section 11 of full monograph). |
Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation, because this listing covers more than one of them.
Substance and classification
| Active substance | Plecanatide |
|---|---|
| ATC code | A06AX07 |
| AHFS class | 56:92.00 |
| Biosimilar biologic | No |
Health Canada record and identifiers
The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.
| DIN (8-digit, as used in ordering) | 02493012 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2493012 |
| Brand name | TRULANCE |
| Generic / active ingredient | PLECANATIDE : 3 MG |
| Market authorization holder | BAUSCH HEALTH, CANADA INC. |
| Health Canada schedule | Prescription |
| ATC code | A06AX07 |
| ATC anatomical main group | A — Alimentary tract and metabolism |
| ATC therapeutic subgroup | A06AX |
| Current status | MARKETED |
| Status date | 12-Jan-2022 |
| Original market date | 2022-01-12 00:00:00 |
| Status source | Live Health Canada DPD sync |
Verify on the primary sources
How is it administered?
Recommended dose: 3 mg orally once daily with or without food. Tablets should be swallowed whole; can be crushed in applesauce or water for patients with swallowing difficulties.
Included because it drives pack selection and wastage. Consult the monograph.
Contraindications
Hypersensitivity to plecanatide or any ingredient; pediatric patients less than 6 years of age; known or suspected mechanical gastrointestinal obstruction.
Warnings and precautions
Serious Warning: Risk of serious dehydration in pediatric patients. If severe diarrhea occurs, suspend dosing and rehydrate the patient.
What can be used instead?
Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.
2 · Same class — other molecules in ATC A06AX
| Molecule | Canadian brands | DINs | Marketed | Sourceable |
|---|---|---|---|---|
| Prucalopride | APO-PRUCALOPRIDE · JAMP PRUCALOPRIDE · NRA-PRUCALOPRIDE · PMS-PRUCALOPRIDE · +2 more | 12 | 10 | Yes |
| Linaclotide | CONSTELLA | 3 | 3 | Yes |
| Plecanatide | TRULANCE | 1 | 1 | Yes |
| Glycerol | GLY-RECTAL SUP POUR ADULTES · GLYCERIN LIQ · GLYCERIN LIQUID · GLYCERIN SUPPOSITORIES · +7 more | 11 | 0 | Not in Canada |
| Other Laxatives | DYCHOLIUM TABLET 300MG | 1 | 0 | Not in Canada |
| Lubiprostone | AMITIZA | 1 | 0 | Not in Canada |
| Tenapanor | IBSRELA | 1 | 0 | Not in Canada |
A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.
3 · Adjacent classes in ATC A06A
| ATC subgroup | Molecules | DINs | Marketed |
|---|---|---|---|
| A06AB | Bisacodyl · Bisacodyl, Combinations · Cascara · Cascara, Combinations · Castor Oil · +9 more | 239 | 25 |
| A06AA | Docusate Sodium · Docusate Sodium, Combinations · Liquid Paraffin · Liquid Paraffin, Combinations | 144 | 22 |
| A06AD | Lactulose · Macrogol · Macrogol, Combinations · Magnesium Oxide · Magnesium Sulphate · +5 more | 86 | 21 |
| A06AH | Methylnaltrexone Bromide · Naloxegol | 5 | 3 |
| A06AG | Bisacodyl · Combinations · Docusate Sodium, Incl Combinations · Sodium Phosphate | 7 | 1 |
| A06AC | Ispaghula (Psylla Seeds) · Ispaghula, Combinations · Linseed · Methylcellulose · Polycarbophil Calcium · +2 more | 79 | 0 |
Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Why is there no price on this page?
Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.